HDAC9 and melanoma: It has also been suggested that epigenetic remodeling may tune the radiosensitivity of cancer cells; in fact, HDAC inhibitors, given their demonstrated ability to restore the apoptosome in melanoma, may radiosensitize human melanoma cells, as shown in pre-clinical models [128,129].